E
Cytek Biosciences, Inc. CTKB
$4.14 -$0.03-0.72% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 51.03% -218.24% 925.85% 109.01% -69.14%
Total Depreciation and Amortization 3.61% 5.22% -2.42% 13.27% 0.81%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -34.97% 209.76% -178.66% 2.68% 3.99%
Change in Net Operating Assets -125.92% 155.07% -268.76% -59.80% 338.93%
Cash from Operations 186.40% -106.26% -84.90% 113.10% 56.79%
Capital Expenditure -85.75% 5.03% 11.57% 3.99% -85.71%
Sale of Property, Plant, and Equipment -30.30% -82.72% 809.52% -72.37% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -244.71% 116.49% -320.13% -594.13% 157.82%
Cash from Investing -273.65% 114.90% -301.25% -881.85% 135.14%
Total Debt Issued 100.72% -75.22% 55,600.00% 266.67% -100.22%
Total Debt Repaid 90.65% -992.09% 0.71% -0.72% 0.00%
Issuance of Common Stock 1,866.67% -95.33% 468.03% -88.06% 143.28%
Repurchase of Common Stock 57.12% -51.05% 41.13% -332.00% -1,791.89%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 77.46% -217.17% 69.88% -606.25% -206.08%
Foreign Exchange rate Adjustments 25.00% -180.90% 260.98% -141.69% 33.45%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -475.42% 94.58% -307.03% -277.91% 480.87%